CANbridge Pharmaceuticals Inc. had a revenue of 20.15M in the quarter ending Dec 31, 2024, with 0.00%. This bring the company's revenue in the last twelve months to 85.10M, Increased -10.28%. In the fiscal year ending Dec 31, 2024, CANbridge Pharmaceuticals Inc. had annual revenue of 85.10M with -17.27% growth.